Levetiracetam concentrated solution for injection was approved for marketing by the State Drug Admin2023-06-16
Levetiracetam concentrated solution for injection (5ml:500mg) of our company was developed with Keppra® as the reference preparation according to the technical requirements of consistency evaluation of quality and efficacy.
Compound amino acid (19) propyl glutamine dipeptide injection was approved for drug marketing by the2023-06-16
This product has a wide range of clinical use (can be used in the general practice), and the indication is to provide parenteral nutrition and supplement amino acids for adult patients when enteral nutrition is not feasible, insufficient or contraindicated. This product contains alanyl glutamine and is suitable for adult trauma patients.
Ondansetron hydrochloride injection is pleased to select the seventh batch of national centralized p2023-06-16
Ondansetron is a selective 5-HT3 receptor antagonist, which can effectively suppress or relieve nausea and vomiting caused by cytotoxic chemotherapy drugs and radiotherapy. Ondansetron has a rapid and powerful inhibitory effect on vomiting caused by some strong emetic chemotherapy drugs (such as cisplatin, cyclophosphamide, etc.).
Fluvastatin sodium sustained-release tablets received marketing approval from the State Drug Adminis2023-06-16
Fluvastatin is A hydroxymethylglutaryl-Coenzyme A (HMG-CoA) reductase suppressant for patients with primary hypercholesterolemia and mixed dyslipidemia (FredricksonⅡa and Ⅱb types) that is not fully controlled by diet.